Sg Americas Securities, LLC Biogen Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 3,675 shares of BIIB stock, worth $591,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,675

Previous 40,190 90.86%

Holding current value

$591,123

Previous $9.32 Million 92.36%

% of portfolio

0.0%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$189.07 - $236.8 $6.9 Million - $8.65 Million	-36,515 Reduced 90.86%	3,675 $712,000
Q2 2024 Jul 12, 2024	SELL	$190.52 - $236.72 $25.9 Million - $32.2 Million	-136,072 Reduced 77.2%	40,190 $9.32 Million
Q1 2024 May 06, 2024	BUY	$212.02 - $267.71 $34.4 Million - $43.4 Million	162,083 Added 1143.12%	176,262 $38 Million
Q4 2023 Jan 12, 2024	SELL	$222.59 - $267.94 $531,322 - $639,572	-2,387 Reduced 14.41%	14,179 $3.67 Million
Q3 2023 Oct 13, 2023	SELL	$253.3 - $285.89 $377,163 - $425,690	-1,489 Reduced 8.25%	16,566 $4.26 Million
Q2 2023 Jul 10, 2023	BUY	$275.25 - $318.06 $1.26 Million - $1.45 Million	4,570 Added 33.89%	18,055 $5.14 Million
Q1 2023 Apr 28, 2023	SELL	$256.56 - $292.34 $3.51 Million - $4.01 Million	-13,700 Reduced 50.4%	13,485 $3.75 Million
Q4 2022 Feb 02, 2023	BUY	$252.44 - $306.72 $5.1 Million - $6.2 Million	20,213 Added 289.92%	27,185 $7.53 Million
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $447,981 - $617,726	-2,301 Reduced 24.81%	6,972 $1.86 Million
Q2 2022 Jul 29, 2022	SELL	$187.54 - $223.02 $10.5 Million - $12.5 Million	-56,121 Reduced 85.82%	9,273 $1.89 Million
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $6.32 Million - $7.97 Million	32,639 Added 99.65%	65,394 $13.8 Million
Q4 2021 Feb 07, 2022	BUY	$223.92 - $287.77 $2.57 Million - $3.3 Million	11,456 Added 53.79%	32,755 $7.86 Million
Q3 2021 Nov 01, 2021	BUY	$282.99 - $369.05 $2.39 Million - $3.12 Million	8,455 Added 65.83%	21,299 $6.03 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $4.44 Million - $7.12 Million	-17,157 Reduced 57.19%	12,844 $4.45 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $7.33 Million - $8.59 Million	-30,168 Reduced 50.14%	30,001 $8.39 Million
Q4 2020 Feb 04, 2021	BUY	$236.26 - $355.63 $6.69 Million - $10.1 Million	28,332 Added 88.99%	60,169 $14.7 Million
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $6.19 Million - $7.14 Million	-23,366 Reduced 42.33%	31,837 $9.03 Million
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $12 Million - $15.9 Million	46,308 Added 520.61%	55,203 $14.8 Million
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $3.55 Million - $4.51 Million	-13,217 Reduced 59.77%	8,895 $2.81 Million
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $7.4 Million - $10.2 Million	-33,640 Reduced 60.34%	22,112 $6.56 Million
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $3.88 Million - $4.35 Million	-17,829 Reduced 24.23%	55,752 $13 Million
Q2 2019 Jul 29, 2019	BUY	$219.29 - $241.72 $6.47 Million - $7.13 Million	29,500 Added 66.92%	73,581 $17.2 Million
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $7.51 Million - $11.8 Million	34,669 Added 368.35%	44,081 $10.4 Million
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $12.4 Million - $15.7 Million	-44,414 Reduced 82.51%	9,412 $2.83 Million
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $6.13 Million - $8.02 Million	20,884 Added 63.4%	53,826 $19 Million
Q2 2018 Aug 07, 2018	BUY	$257.52 - $306.91 $1.54 Million - $1.84 Million	5,997 Added 22.26%	32,942 $9.56 Million
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $1.23 Million - $1.74 Million	-4,743 Reduced 14.97%	26,945 $7.38 Million
Q4 2017 Jan 24, 2018	BUY	$307.64 - $344.58 $394,086 - $441,406	1,281 Added 4.21%	31,688 $10.1 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $8.55 Million - $10 Million	30,407	30,407 $9.52 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Biogen Inc. Transaction History